| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10965272 | Vaccine | 2014 | 8 Pages |
Abstract
A GMMA vaccine produced from a recombinant African N. meningitidis W strain with deleted capsule locus, lpxL1, gna33 and overexpressed fHbp v.1 has potential as an affordable vaccine with broad coverage against strains from all main serogroups currently causing meningococcal meningitis in sub-Saharan Africa.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Oliver Koeberling, Emma Ispasanie, Julia Hauser, Omar Rossi, Gerd Pluschke, Dominique A. Caugant, Allan Saul, Calman A. MacLennan,